Nasdaq 100 Stocks SEC Filings — June 02, 2026

USA NASDAQ-100

By Gunpowder Editorial ·

12 high priority 16 medium priority 28 total filings analysed

Executive Summary

The 28 filings from NASDAQ-100 constituents and related entities reveal a market bifurcated between aggressive M&A and capital returns versus defensive governance battles and early-stage biotech catalysts.

The most significant development is the definitive agreement for Weatherford (WFRD) to acquire NCS Multistage (NCSM), a deal with over 50% shareholder approval already secured and expected to be immediately accretive to free cash flow, signaling consolidation in the energy services sector. Concurrently, a high-stakes proxy fight is unfolding at Genco Shipping (GNK), where Diana Shipping's $24.80/share tender offer has been unanimously rejected by the board as inadequate, with the annual meeting on June 18 serving as a critical inflection point. On the positive side, Inmune Bio reported statistically significant Phase 2 Alzheimer's data with a clean safety profile, while Kennametal (KMT) secured a $200M increase in credit commitments, indicating financial flexibility. However, shareholder dissent on executive compensation at Saga Communications (SGA) and the ongoing capital raise at Cottonwood Communities highlight governance and capital allocation concerns. Period-over-period comparisons were limited in these filings, but the forward-looking data points to a busy catalyst calendar with the Genco meeting, Inmune's Phase 2b/3 plans, and the NCSM deal closing in H2 2026.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 425 · DEFA14A · Schedule 13D · DEF 14A · S-1

Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from June 01, 2026.

Investment Signals (10)

  • Weatherford (WFRD) / NCS Multistage (NCSM)

    Acquisition of NCSM is expected to be immediately accretive to adjusted free cash flow per share with at least $15M in annual cost synergies within 18 months. The controlling stockholder (>50%) has already approved, removing deal risk. [BULLISH for WFRD]

  • Inmune Bio (INMB) (BULLISH)

    Phase 2 MINDFuL trial met primary biomarker endpoint with p=0.0028 (d=0.46) in full population and p=0.0098 (d=0.59) in biomarker-enriched patients. No ARIA-E or ARIA-H observed, differentiating from amyloid-clearing therapies. FDA Fast Track granted May 14, 2026.

  • Genco Shipping (GNK)

    Board unanimously recommends rejecting Diana Shipping's $24.80/share tender offer, which is below the mean analyst NAV estimate of $26.66 and median NAV of $27.10. Jefferies opined the offer is inadequate. [BULLISH for GNK shareholders holding out for higher price]

  • Mueller Industries (MLI) (BULLISH)

    Announced a 2-for-1 forward stock split, effective June 30, 2026. Record date is June 25. This signals management confidence and can attract retail investors.

  • Kennametal (KMT) (BULLISH)

    Increased credit facility commitments by $200M to $850M and added a new $600M Term Loan, plus a $350M incremental debt basket. This provides significant financial flexibility for M&A or capex.

  • Diana Shipping (DSX)

    Has rapidly accumulated a 14.4% stake in Genco and launched a hostile tender offer at $24.80. The offer has been rejected three times, but Diana is pushing for board change at the June 18 AGM. [BEARISH for GNK if Diana gains control]

  • Saga Communications (SGA) (BEARISH)

    Say-on-pay proposal received only 63.2% approval, with 1.76M shares voted against. This is a strong signal of shareholder discontent with executive compensation.

  • Continued selling Series A Convertible Preferred Stock under Regulation D, raising $2.006M in net proceeds from May 15 to June 1. No update on cumulative capital raised against the $200M maximum or deployment strategy. [NEUTRAL/BEARISH for lack of transparency]

  • Texas Instruments (TXN)

    Appointed Julie Knecht as CFO, a 25-year veteran, succeeding Rafael Lizardi who is retiring. The transition is orderly and not related to any financial concerns, indicating stability. [NEUTRAL/BULLISH]

  • Intelligent Bio Solutions (INBS)

    Initiated a multi-site Method Comparison Study to support FDA 510(k) submission for its opiate codeine drug screening system. This is a key regulatory milestone. [BULLISH if FDA clearance is obtained]

Risk Flags (8)

  • Genco Shipping (GNK) / Hostile Takeover [HIGH RISK]

    Diana Shipping has launched a tender offer at $24.80/share and is seeking to replace six directors at the June 18 AGM. The board has spent over $13M defending against the offer, plus an additional $2M on fairness opinions. The outcome is uncertain and could result in a change of control at a price deemed inadequate.

  • NCS Multistage (NCSM) / Deal Execution [MEDIUM RISK]

    While the deal has majority shareholder approval, it is subject to regulatory approvals and customary closing conditions. Any delay or failure to close in H2 2026 would be negative.

  • Saga Communications (SGA) / Governance Risk [MEDIUM RISK]

    The say-on-pay vote with 36.8% opposition is a significant red flag. This could lead to activist engagement or further shareholder dissent at future meetings.

  • The S-1 filing highlights potential material weaknesses in internal controls, anti-takeover provisions, and exposure to geopolitical and commodity price volatility. Investors in the IPO face significant uncertainty.

  • Inmune Bio (INMB) / Clinical Risk [HIGH RISK]

    The Phase 2 results are from exploratory analyses. The Phase 2b/3 program is still early-stage, and there is no approved product. Failure in the next phase would be a complete loss.

  • The company has been raising capital since September 2023 with no stated use of proceeds or update on cumulative funds raised. This lack of transparency is a concern for investors.

  • Chemung Financial (CHMG) / Director Support [LOW RISK]

    Director Stephen M. Lounsberry III received 372,554 votes withheld (11.3% of votes cast), significantly higher than other nominees. This suggests some shareholder dissatisfaction.

  • The drilling results are visual only, and the company cautions that inferred/indicated resources may not become economically mineable. This is a high-risk exploration stage company.

Opportunities (8)

  • Inmune Bio (INMB) / Alzheimer's Catalyst (OPPORTUNITY)

    With statistically significant Phase 2 data, a clean safety profile (no ARIA), and FDA Fast Track designation, INMB is positioned for a potential Phase 2b/3 registrational program. The biomarker-enriched subgroup showed a d=0.59 effect size.

  • Genco Shipping (GNK) / Merger Arbitrage (OPPORTUNITY)

    The spread between Diana's $24.80 offer and the analyst NAV estimates ($26.66-$27.10) presents an opportunity. If the board successfully defends or finds a higher bidder, shareholders could realize a premium.

  • Weatherford (WFRD) / Synergy Realization (OPPORTUNITY)

    The NCSM acquisition is expected to deliver at least $15M in annual cost synergies within 18 months and be immediately accretive to free cash flow. This could drive significant EPS growth for WFRD.

  • Mueller Industries (MLI) / Stock Split Catalyst (OPPORTUNITY)

    The 2-for-1 stock split could lower the share price and attract retail investors, potentially driving short-term momentum. Record date is June 25, split effective June 30.

  • Kennametal (KMT) / Balance Sheet Strength (OPPORTUNITY)

    The $200M increase in credit commitments and new $600M term loan provide KMT with significant firepower for strategic acquisitions or share buybacks.

  • Intelligent Bio Solutions (INBS) / FDA Clearance Catalyst (OPPORTUNITY)

    If the Method Comparison Study is successful, the company will be one step closer to FDA 510(k) clearance for its drug screening system, opening the U.S. market.

  • Maui Land & Pineapple (MLP) / Asset Monetization (OPPORTUNITY)

    The sale of 8.783 acres in Kapalua for $10M plus potential additional land sales provides a clear path to value realization. The deal includes a master lease of retail space, maintaining some ongoing revenue.

  • NCS Multistage (NCSM) / Takeover Premium (OPPORTUNITY)

    NCSM shareholders are receiving a premium via the Weatherford acquisition. The deal has majority approval, reducing risk. The election between stock and cash consideration allows for tax optimization.

Sector Themes (6)

  • Energy Services Consolidation

    The Weatherford-NCSM deal is a clear signal of consolidation in the oilfield services sector, driven by the need for scale and integrated well-life solutions. Expect more M&A as larger players seek to acquire technology and market share. [IMPLICATION: Watch for other small-cap energy service targets]

  • Maritime Proxy Battles Intensify

    The Genco-Diana fight is a high-profile example of activist activity in the shipping sector. Diana's rapid accumulation of a 14.4% stake and hostile tender offer highlights the vulnerability of companies trading below NAV. [IMPLICATION: Other shipping companies with low valuations relative to NAV could be targets]

  • Biotech Focus on Alzheimer's with Differentiated Safety

    Inmune Bio's clean safety profile (no ARIA) in its Alzheimer's trial is a significant differentiator from amyloid-clearing therapies. This could shift investor focus towards anti-inflammatory approaches. [IMPLICATION: Monitor other companies targeting neuroinflammation]

  • Shareholder Activism on Governance and Pay

    Saga Communications' 36.8% opposition to say-on-pay and Chemung Financial's director with 11.3% withheld votes indicate growing shareholder scrutiny on compensation and board composition. [IMPLICATION: Companies with poor governance practices may face increased activism]

  • Capital Raising Through Preferred Stock

    Cottonwood Communities' continued sale of convertible preferred stock under Regulation D shows a trend of non-dilutive (at the common level) capital raising for REITs and other capital-intensive businesses. [IMPLICATION: Monitor for similar offerings from other companies]

  • Infrastructure and Utility Investment

    TXNM Energy's subsidiaries filing for base rate reviews and carbon-free generation resources signals ongoing capital investment in regulated utilities. This is a long-term theme supporting rate base growth. [IMPLICATION: Favorable for regulated utilities with constructive regulatory environments]

Watch List (8)

  • Genco Shipping (GNK) / Annual Meeting (HIGH IMPACT)
    👁

    June 18, 2026. Shareholders will vote on replacing six directors. The outcome will determine the fate of Diana Shipping's hostile takeover attempt.

  • Genco Shipping (GNK) / Tender Offer Expiration (HIGH IMPACT)
    👁

    June 26, 2026. Diana Shipping's $24.80/share tender offer expires. Watch for any increase in the offer or competing bids.

  • Inmune Bio (INMB) / Phase 2b/3 Trial Design (MEDIUM IMPACT)
    👁

    The company has FDA End-of-Phase 2 alignment. Watch for details on the seamless adaptive trial design and enrollment timeline.

  • NCS Multistage (NCSM) / Weatherford (WFRD) Deal Close (MEDIUM IMPACT)
    👁

    Expected in H2 2026. Subject to regulatory approvals. Any updates on the timeline or regulatory hurdles will move the stock.

  • Mueller Industries (MLI) / Stock Split Record Date (LOW IMPACT)
    👁

    June 25, 2026. Investors must be on record to receive the additional share. The split-adjusted trading begins July 1.

  • Intelligent Bio Solutions (INBS) / FDA 510(k) Submission (MEDIUM IMPACT)
    👁

    The company has initiated the study to support submission. Watch for completion of the study and actual submission date.

  • Maui Land & Pineapple (MLP) / Due Diligence Period (MEDIUM IMPACT)
    👁

    The buyer has a 90-day due diligence period from May 27, 2026. Watch for any termination or renegotiation of the purchase agreement.

  • 👁

    The S-1 registration statement has been filed. Watch for the IPO pricing and initial trading performance, which will signal investor appetite for mining IPOs.

Filing Analyses (28)
NCS Multistage Holdings, Inc. 8-K positive materiality 9/10

02-06-2026

Weatherford International plc (NASDAQ: WFRD) has entered into a definitive agreement to acquire NCS Multistage Holdings, Inc. (NASDAQ: NCSM) in a stock-and-cash transaction. Under the terms, NCS Multistage stockholders can elect to receive either 0.554 shares of Weatherford common stock or a combination of 0.239 shares plus a cash amount equivalent to 0.137 shares, with a blended consideration of 0.463 Weatherford shares per NCSM share and up to 19.99% payable in cash. The deal is expected to close in the second half of 2026, subject to regulatory approvals, and is expected to be immediately accretive to adjusted free cash flow per share with at least $15 million in annual cost synergies within 18 months of closing. The transaction has been approved by both boards and the controlling stockholder of NCS Multistage, which owns more than 50% of its outstanding common stock.

  • · The transaction has been approved by the controlling stockholder of NCS Multistage that owns more than 50% of its outstanding common stock.
  • · Weatherford expects to realize at least $15 million in annual run-rate cost synergies within 18 months of closing.
  • · The deal is expected to be immediately accretive to adjusted Free Cash Flow per share.
  • · NCS Multistage stockholders can elect either 0.554 shares of Weatherford common stock or a combination of 0.239 shares plus cash equivalent to 0.137 shares, subject to proration.
  • · Up to 19.99% of the total equity consideration is payable in cash.
  • · The transaction is expected to close in the second half of 2026, subject to customary closing conditions including regulatory approvals.
  • · Until closing, Weatherford and NCS Multistage will continue to operate as separate, independent companies.
NCS Multistage Holdings, Inc. 425 neutral materiality 8/10

02-06-2026

NCS Multistage Holdings, Inc. has entered into a definitive agreement to be acquired by Weatherford International, with a share exchange ratio of 0.5537 Weatherford shares for each NCS share. The filing details the treatment of employee long-term incentive (LTI) awards, including the conversion of RSUs and ESUs into Weatherford equity awards, with ESU holders benefiting from removal of maximum value caps (ranging from $30.78 to $77.62 per share depending on grant date). The transaction is subject to regulatory approvals and customary closing conditions, and no financial performance metrics or period-over-period comparisons are provided in this communication.

  • · The share exchange ratio is 0.5537 Weatherford shares for each NCS share.
  • · ESU maximum value caps: $30.78 (March 2024), $57.62 (March 2025), $61.34 (July 2025), $77.62 (March 2026) per share.
  • · ESUs will be converted from cash-settled to equity-settled awards (RSUs in Weatherford shares) and the maximum value cap will be removed upon conversion.
  • · RSUs will be assumed by Weatherford and converted into RSUs payable in Weatherford shares with the same vesting schedule.
  • · The transaction is subject to regulatory approvals and customary closing conditions; closing is not guaranteed.
  • · Insider trading restrictions continue to apply both before and after closing.
GENCO SHIPPING & TRADING LTD 8-K neutral materiality 5/10

02-06-2026

On June 2, 2026, Genco Shipping & Trading Limited entered into the Third Amendment to its Shareholder Rights Agreement, eliminating the defined term 'Acting in Concert' based on shareholder feedback and board assessment. The amendment does not alter other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), and the Rights Agreement remains substantially similar to those of other public companies, intended to protect shareholder long-term value and prevent coercive control without a premium.

  • · The Third Amendment was entered into on June 2, 2026.
  • · The amendment eliminates the defined term 'Acting in Concert' from the Rights Agreement.
  • · Other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), remain unchanged.
  • · The Rights Agreement was originally dated October 1, 2025.
  • · The amendment is intended to enable all shareholders to realize long-term value and provide the Board sufficient time to fulfill fiduciary duties.
NexMetals Mining Corp. 8-K neutral materiality 3/10

02-06-2026

NexMetals Mining Corp. issued a press release on June 1, 2026, reporting visual results from its ongoing 30,000-metre surface drilling program targeting the emerging Flexure Zone at the Selebi Main deposit in Botswana. The disclosure includes cautionary statements about mineral resource estimates under NI 43-101, emphasizing the uncertainty and that no assurance can be given that inferred or indicated resources will become economically mineable reserves.

  • · The drilling program is targeting the emerging Flexure Zone at the Selebi Main deposit in Botswana.
  • · The press release was furnished under Regulation FD and is not deemed filed under the Exchange Act.
  • · Resource estimates use Canadian NI 43-101 standards, which differ from SEC S-K 1300 rules; investors are cautioned that indicated and inferred resources may not become economically mineable.
NCS Multistage Holdings, Inc. 425 neutral materiality 9/10

02-06-2026

NCS Multistage Holdings, Inc. has entered into a definitive merger agreement with Weatherford International plc, under which Weatherford will acquire NCS in an all-stock and mixed consideration transaction expected to close in the second half of 2026. Holders of more than 50% of NCS common stock have already consented to the merger, eliminating the need for further stockholder approval.

  • · The Merger Agreement includes a no-shop clause and provisions for superior proposals.
  • · NCS restricted stock units (RSUs) and equivalent stock units (ESUs) will be assumed by Weatherford, with terms continuing including vesting, but the Max Value Cap on ESUs will cease.
  • · NCS performance stock units (PSUs) will be assumed with performance goals deemed satisfied at the greater of target and actual level as of the Merger Agreement date.
  • · NCS options with an exercise price less than the value of the Share Consideration will be assumed and converted; those with an exercise price equal to or greater will be cancelled without consideration.
  • · Non-employee director NCS DSUs will automatically vest and settle in NCS common stock immediately prior to the Effective Time.
  • · The Outside Date for closing is May 31, 2027, after which either party may terminate if the merger has not been completed.
  • · The Merger is subject to customary closing conditions including regulatory approvals, effectiveness of an S-4 registration statement, and no Material Adverse Effect.
NCS Multistage Holdings, Inc. 425 neutral materiality 8/10

02-06-2026

NCS Multistage Holdings, Inc. has agreed to be acquired by Weatherford International plc in a cash-and-stock transaction, with the deal expected to close in the second half of 2026. The combination aims to leverage Weatherford's global scale and technology to offer broader integrated well-life solutions, while NCS, Repeat Precision, and ResMetrics will continue operating independently until closing. No financial terms or performance metrics were disclosed in this communication.

  • · The acquisition consideration consists of cash and stock (no specific amounts disclosed).
  • · The transaction is subject to customary closing conditions, including regulatory approvals.
  • · NCS, Repeat Precision, and ResMetrics will each continue to operate under their current names with the same teams until closing.
  • · Suppliers are instructed to continue sending invoices to the same groups and maintain day-to-day contacts.
  • · Weatherford is described as a leading global energy services company with a portfolio across drilling, well construction, completions, and production.
NCS Multistage Holdings, Inc. 425 neutral materiality 9/10

02-06-2026

NCS Multistage Holdings, Inc. announced it has agreed to be acquired by Weatherford International plc in a cash-and-stock transaction expected to close in the second half of 2026, subject to regulatory approvals and customary conditions. The combination aims to deliver a broader, more integrated set of well-life solutions leveraging Weatherford's global scale and technology. Until closing, NCS, Repeat Precision, and ResMetrics will continue to operate independently with no changes to products, services, or commercial agreements.

  • · The acquisition consideration consists of cash and stock (specific terms not disclosed in this filing).
  • · The transaction is expected to close in the second half of 2026.
  • · Closing is subject to customary conditions including regulatory approvals.
  • · NCS, Repeat Precision, and ResMetrics will each continue to operate under their current names with the same teams, products, and points of contact until closing.
  • · No changes to current product offerings, services, or commercial agreements as a result of the pending transaction.
TXNM ENERGY INC 8-K neutral materiality 5/10

02-06-2026

TXNM Energy's subsidiaries filed two key regulatory actions on May 29, 2026: TNMP filed a comprehensive settlement in its base rate review with the PUCT, and PNM filed an application with the NMPRC to advance carbon-free generation resources. The filings are disclosed under Regulation FD and Item 8.01, with no financial figures or performance metrics provided in the 8-K.

  • · TNMP's base rate review settlement was filed with the Public Utility Commission of Texas (PUCT) on May 29, 2026.
  • · PNM's application for carbon-free generation resources was filed with the New Mexico Public Regulatory Commission (NMPRC) on May 29, 2026.
  • · The press releases are furnished as Exhibits 99.1 and 99.2 and are not deemed filed under the Exchange Act.
GENCO SHIPPING & TRADING LTD DEFA14A mixed materiality 8/10

02-06-2026

Genco Shipping & Trading Ltd. filed a DEFA14A (additional proxy material) urging shareholders to vote FOR its six incumbent directors and AGAINST Diana Shipping Inc.'s unsolicited tender offer of $24.80 per share, which the Board unanimously deems inadequate. The Board highlights that the offer is below Genco's mean analyst NAV estimate of $26.66 and median NAV estimate of $27.10, and that Diana's nominees have ties to bankruptcy and shareholder value destruction. However, the filing also acknowledges that Diana has rapidly acquired a significant ownership stake and launched a tender offer, creating uncertainty and a contested proxy battle.

  • · Genco's Board unanimously recommends rejecting Diana's $24.80 tender offer and not tendering shares.
  • · The Board has engaged with Diana for two years, starting with Genco's outreach in June 2024 to discuss a potential business combination.
  • · Diana has rapidly acquired a significant ownership stake in Genco and launched a tender offer.
  • · Certain of Diana's nominees have records of bankruptcy and shareholder value destruction.
  • · Half of Genco's Board is female.
  • · The filing includes forward-looking statements and disclaimers regarding dividend payments, which depend on various factors including credit agreements, Marshall Islands law, and Board discretion.
GENCO SHIPPING & TRADING LTD SC 14D9/A negative materiality 9/10

02-06-2026

Genco Shipping & Trading Ltd has filed a solicitation/recommendation statement (SC 14D9/A) in response to Diana Shipping Inc.'s amended tender offer to acquire all outstanding shares of Genco at $24.80 per share in cash, increased from the original $23.50. The filing includes fairness opinions from Jefferies LLC and Morgan Stanley & Co. LLC, with Jefferies opining that the $24.80 per share consideration is inadequate from a financial point of view to Genco shareholders (excluding Diana and its affiliates). The offer expires on June 26, 2026.

  • · The Offer has been extended and the expiration date is June 26, 2026 at 5:00 p.m. New York City time.
  • · Jefferies LLC, as financial advisor to Genco, opined that the $24.80 per share consideration is inadequate from a financial point of view to holders of Common Shares (other than Diana and its affiliates).
  • · Morgan Stanley & Co. LLC also provided a fairness opinion dated June 1, 2026 (full text not included in this excerpt).
  • · Genco's Board has appointed a Strategic Committee to evaluate the Offer.
  • · Diana has entered into a purchase and sale agreement with Star Bulk Carriers Corp., under which Star Bulk will acquire certain assets of Genco, conditioned on Diana completing its acquisition of Genco.
  • · Jefferies LLC has provided financial advisory services to Genco over the past two years totaling approximately $6.75 million, including for a 2024 proxy contest and prior Diana proposals.
  • · The Schedule TO (Diana's tender offer statement) was originally filed on May 4, 2026 and subsequently amended multiple times (May 7, 12, 18, 19, 27, 2026).
TEXAS INSTRUMENTS INC 8-K neutral materiality 5/10

02-06-2026

Texas Instruments announced the appointment of Julie Knecht as Senior Vice President and CFO (Chief Accounting Officer), effective August 1, 2026, succeeding Rafael Lizardi, who is retiring after 25 years with the company. Ms. Knecht, a 25-year TI veteran currently serving as VP and Chief Accounting Officer, will receive an annual base salary of $700,000 and $2 million in restricted stock units. The filing notes that Mr. Lizardi's retirement is not related to any financial or reporting concerns.

  • · Julie Knecht, age 54, has been with Texas Instruments for over 25 years, most recently as Vice President and Chief Accounting Officer since 2021.
  • · Rafael Lizardi's retirement is effective August 1, 2026, after 25 years with the company.
  • · The separation agreement with Mr. Lizardi is described on page 46 of the company's 2026 Proxy Statement.
  • · The appointment was made by the Board on May 27, 2026.
GENCO SHIPPING & TRADING LTD SC 13D/A negative materiality 9/10

02-06-2026

Diana Shipping Inc. filed an amended Schedule 13D/A disclosing that its wholly-owned subsidiary, 4 Dragon Merger Sub Inc., beneficially owns 6,264,548 shares (14.4%) of Genco Shipping & Trading Ltd. Diana is conducting a cash tender offer at $24.80 per share to acquire all outstanding Genco shares, which the Genco Board has rejected for the third time without engagement. Diana is now urging Genco shareholders to replace six Genco directors at the June 18 annual meeting and to tender their shares by June 26, 2026.

  • · Genco has revised its poison pill in response to shareholder feedback, indicating it was overly aggressive.
  • · Genco spent an additional $2 million on inadequacy opinions from Jefferies and Morgan Stanley, on top of over $13 million already spent to defeat Diana's offers.
  • · Diana's two most recent offers reflected nearly 100% of Genco's NAV based on VesselsValue broker valuations, consistent with Genco's own historical practice.
  • · Genco changed its valuation source from VesselsValue to sell-side analyst estimates, resulting in higher NAV figures used to justify rejection.
  • · The tender offer expires at 5:00 p.m. New York City time on June 26, 2026, unless extended.
  • · The annual meeting is scheduled for June 18, 2026.
  • · Shareholders who already voted the WHITE card can change their vote by using the GOLD universal proxy card.
MAUI LAND & PINEAPPLE CO INC 8-K neutral materiality 7/10

02-06-2026

Maui Land & Pineapple Company, Inc. (MLP) entered into a Purchase and Sale Agreement on May 27, 2026, to sell 8.783 acres of land (Lot 2-D) and up to 3.5 acres of adjacent land in Kapalua, Maui, to DC Kapalua 1 Property, LLC for a base price of $10,000,000 plus $1,138,565 per acre for the additional land. The agreement includes a 90-day due diligence period, customary earnest money deposits, and conditions related to governmental approvals, with potential termination rights if approvals are not secured. The transaction also provides for a non-exclusive trademark license, a master lease of retail space to MLP, and access to amenities for Kapalua Club members.

  • · The Purchase Agreement includes a non-exclusive license to use certain MLP trademarks, a master lease of new street front retail space in Kapalua Village from Buyer to MLP, and access to amenities for Kapalua Club members.
  • · Earnest money deposits become nonrefundable based on time elapsed after the Acceptance Date; if Buyer terminates or fails to deliver Acceptance Notice during due diligence, all deposits are refundable.
  • · The full Purchase Agreement will be filed as an exhibit to MLP's Quarterly Report on Form 10-Q on or before August 14, 2026.
BLACKROCK MUNIYIELD PENNSYLVANIA QUALITY FUND DEF 14A neutral materiality 3/10

02-06-2026

BlackRock MuniYield Pennsylvania Quality Fund (MPA) filed a definitive proxy statement (DEF 14A) on June 2, 2026, for its annual shareholder meeting to be held virtually on July 22, 2026. The sole proposal is the election of Board Nominees, unanimously recommended by the Board. The Fund will bear all proxy costs, including an estimated $11,800 fee to proxy solicitor Georgeson LLC.

  • · The annual meeting will be held virtually on July 22, 2026 at 10:30 a.m. Eastern Time.
  • · Record date for shareholders is May 26, 2026.
  • · Shareholders can vote by telephone, internet, ProxyVote app, mail, or at the virtual meeting.
  • · Beneficial shareholders must register in advance to vote at the meeting by submitting a legal proxy to shareholdermeetings@computershare.com by 5:00 p.m. ET three business days before the meeting.
  • · If a proxy card is submitted without voting instructions, shares will be voted FOR the Board Nominees.
  • · The Fund's Board has unanimously approved the nominees and recommends a vote FOR each.
  • · The Fund will bear all costs of the proxy solicitation, including legal and auditor fees.
COMCAST CORP 8-K neutral materiality 1/10

02-06-2026

Comcast Corporation filed a Form 8-K on June 2, 2026, to report an other event under Item 8.01, attaching a press release dated the same day as Exhibit 99.1. The filing does not disclose any financial results, material transactions, or period-over-period comparisons, and no quantitative data or named initiatives are provided.

  • · The filing includes a list of 12 classes of registered securities, including Class A Common Stock (CMCSA) and various notes and debentures traded on Nasdaq and NYSE.
  • · The press release (Exhibit 99.1) is incorporated by reference but its content is not summarized in the filing.
CHEMUNG FINANCIAL CORP 8-K positive materiality 3/10

02-06-2026

Chemung Financial Corporation held its Annual Meeting on June 2, 2026, where shareholders voted on three proposals. All four director nominees were elected, the say-on-pay proposal was approved, and the ratification of Crowe LLP as independent auditor for 2026 was passed. No negative or flat metrics were present in the filing.

  • · Proposal 1: Director elections – Richard E. Forrestel Jr. received 3,222,817 votes for and 68,126 withheld; Stephen M. Lounsberry III received 2,918,389 for and 372,554 withheld; Anders M. Tomson received 3,266,034 for and 24,909 withheld; G. Thomas Tranter Jr. received 3,195,518 for and 95,425 withheld. Broker non-votes were 1,205,465 for each.
  • · Proposal 2: Say-on-Pay – 3,150,781 votes for, 122,780 against, 17,382 abstained, with 1,205,465 broker non-votes.
  • · Proposal 3: Ratification of Crowe LLP – 4,452,309 votes for, 42,148 against, 1,951 abstain.
Booking Holdings Inc. 8-K neutral materiality 3/10

02-06-2026

Booking Holdings held its 2026 Annual Meeting on June 2, 2026, where all 11 director nominees were elected, including Glenn D. Fogel and Nicholas J. Read. Stockholders approved advisory executive compensation, ratified Deloitte & Touche as auditor, and approved an officer exculpation charter amendment. However, two stockholder proposals—one on political spending and another on illegal settlements—were both rejected by wide margins.

  • · Charles H. Noski received the lowest support among directors with 568,161,578 votes for (90.4% of votes cast), while Glenn D. Fogel received the highest with 626,172,624 votes for (99.5%).
  • · The advisory vote on executive compensation passed with 567,003,024 votes for (90.2% of votes cast).
  • · The officer exculpation amendment was approved with 549,857,878 votes for (87.4% of votes cast).
  • · The stockholder proposal on political spending was rejected with only 220,677,778 votes for (35.2% of votes cast).
  • · The stockholder proposal on illegal settlements was overwhelmingly rejected with only 64,039,145 votes for (10.3% of votes cast).
  • · Ratification of Deloitte & Touche as auditor passed with 610,788,541 votes for (91.4% of votes cast).
Cottonwood Communities, Inc. 8-K neutral materiality 5/10

02-06-2026

Cottonwood Communities, Inc. filed an 8-K reporting the continued sale of Series A Convertible Preferred Stock under its Regulation D private placement offering. From May 15 to June 1, 2026, the company issued 203,263 shares at $10.00/share, raising $2,006,000 in net proceeds, while incurring $96,260 in selling commissions and $59,130 in placement fees. However, the report shows no major operational or financial performance metrics, and the offering remains a capital raise with no stated use of proceeds or context on cumulative capital raised against the $200M maximum.

  • · The offering is a best-efforts private placement exempt under Rule 506(b) of Regulation D, limited to accredited investors without general solicitation.
  • · The offering was launched on September 19, 2023, and remains ongoing with a maximum of $200M.
  • · No update on cumulative proceeds raised since inception or how funds are being deployed.
  • · No other events (e.g., changes in control, material agreements, director/resignation) are reported under other Form 8-K items.
CopperTech Metals Inc. S-1 neutral materiality 8/10

02-06-2026

CopperTech Metals Inc. filed an S-1 registration statement for an IPO on June 2, 2026. The filing highlights significant risks including potential material weaknesses in internal controls, anti-takeover provisions in Delaware law and corporate charter, exclusive forum provisions for litigation, and exposure to geopolitical and economic uncertainties. The company also notes forward-looking statements regarding production goals, AI integration, and commodity price volatility.

  • · The filing includes a cautionary note on forward-looking statements covering production goals, AI integration, and commodity price volatility.
  • · The company's amended and restated bylaws designate Delaware Court of Chancery as exclusive forum for certain stockholder litigation and federal district courts for Securities Act claims.
  • · Anti-takeover provisions include ability to issue preferred stock without stockholder approval, no cumulative voting, and supermajority vote requirements for charter amendments.
  • · Risk factors include potential material weaknesses in internal controls, geopolitical tensions (Middle East, Ukraine, U.S.-China trade war), and exposure to Zambian operations with historical ties to China.
VERIZON COMMUNICATIONS INC 8-K neutral materiality 2/10

02-06-2026

Verizon Communications Inc. filed an 8-K on June 2, 2026, attaching a press release (Exhibit 99.1) as an other event. The filing lists numerous debt securities registered on the NYSE, but no specific financial results or material changes are disclosed in the 8-K itself.

  • · The filing includes a list of 38 debt securities (notes and junior subordinated notes) registered under Section 12(b) of the Exchange Act, with maturities ranging from 2026 to 2056.
  • · Common stock (VZ) is listed on both the New York Stock Exchange and the Nasdaq Global Select Market.
INTELLIGENT BIO SOLUTIONS INC. 8-K positive materiality 5/10

02-06-2026

Intelligent Bio Solutions Inc. announced on June 2, 2026, the initiation of a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for the opiate codeine. This is a regulatory milestone for the company's product, but no financial details or prior performance comparisons were provided in the filing.

MUELLER INDUSTRIES INC 8-K neutral materiality 3/10

02-06-2026

Mueller Industries Inc. announced a two-for-one forward stock split, effective through an amendment to its Restated Certificate of Incorporation. Record holders as of June 25, 2026, will receive one additional share per share, distributed after market close on June 30, 2026, with split-adjusted trading starting July 1, 2026. The filing contains no financial results or performance metrics, so no positive or negative trends are reported.

  • · Record date for the stock split is June 25, 2026.
  • · Distribution of additional shares occurs after market close on June 30, 2026.
  • · Split-adjusted trading begins at market open on July 1, 2026.
  • · The stock split is effected via an amendment to the company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware.
Federal Home Loan Bank of San Francisco 8-K neutral materiality 3/10

02-06-2026

Federal Home Loan Bank of San Francisco filed an 8-K on June 2, 2026, reporting the issuance of a consolidated obligation bond on May 29, 2026, for which it is the primary obligor. The bond has a principal amount of $10,000,000, a fixed coupon of 4.250%, and matures on June 4, 2031. The filing notes that consolidated obligations are joint and several obligations of all eleven Federal Home Loan Banks, are not guaranteed by the U.S. government, and that the Bank has not made a judgment on the materiality of any particular obligation.

  • · The bond has a Bermudan call style, meaning it is redeemable on specified recurring dates on and after the first redemption date (June 4, 2029) until maturity.
  • · The bond is classified as an Optional Principal Redemption bond (callable bond).
  • · Consolidated obligations are sold through authorized securities dealers and are not guaranteed by the United States government.
  • · The filing excludes discount notes with a maturity of one year or less issued in the ordinary course of business.
  • · The Bank may elect to change its method of reporting information on the issuance or assumption of consolidated obligations at any time.
CANADIAN DERIVATIVES CLEARING CORP 8-K neutral materiality 3/10

02-06-2026

This 8-K filing by Canadian Derivatives Clearing Corporation (CDCC), dated May 31, 2026, principally provides an updated list of underlying interests for options traded on the Montreal Exchange and offered in the United States under CDCC's Form S-20 registration statement. The filing contains no financial results, corporate actions, or performance data, serving solely as a regulatory disclosure of securities available for options trading. The list includes a broad range of equity, index, CEF, CDR, and ETF options, but no period-over-period comparisons or quantitative achievements are reported.

  • · The filing was signed by President Karen McMeekin on June 2, 2026.
  • · The list includes 3 index options: S&P/TSX 60 Index Standard Options, S&P/TSX Capped Utilities Index Options, and S&P/TSX Composite Index Banks Options.
  • · Options on CDRs cover 17 major US stocks: AMD, Alphabet, Amazon, Apple, Berkshire Hathaway, Broadcom, Costco, Lululemon, Meta, Micron, Microsoft, Netflix, Nvidia, Palantir, Tesla, Uber, UnitedHealth.
  • · Options on ETFs include crypto-asset ETFs such as 3iQ Bitcoin ETF, 3iQ Ether Staking ETF, CI Galaxy Bitcoin ETF, CI Galaxy Ethereum ETF, Evolve Bitcoin ETF, and Evolve Ether ETF.
  • · Some companies appear with multiple entries having different option symbols (e.g., Cenovus Energy with CVE and CVE1; Eldorado Gold with ELD and ELD1; Maple Leaf Foods with MFI and MFI2; Pan American Silver with PAAS and PAAS1; TELUS with T and T1; Thomson Reuters with TRI and TRI1; Transcontinental with TCL and TCL1; Whitecap Resources with WCP and WCP1).
Inmune Bio, Inc. 8-K positive materiality 8/10

02-06-2026

Inmune Bio reported statistically significant treatment effects on white matter MRI biomarker (chi-separation) in the Phase 2 MINDFuL trial of XPro1595 in early Alzheimer's disease. The full mITT population (n=200) showed p=0.0028 (d=0.46), and biomarker-enriched patients (n=100) showed p=0.0098 (d=0.59). The company has FDA Fast Track designation and End-of-Phase 2 alignment for a Phase 2b/3 registrational program. However, the results are from exploratory analyses and the trial is still early-stage with no approved product.

  • · No ARIA-E or ARIA-H observed in Phase 2 MINDFuL trial, differentiating from amyloid-clearing therapies.
  • · FDA Fast Track designation granted on May 14, 2026.
  • · Phase 2b/3 seamless adaptive trial design uses EMACC and pTau217 for Phase 2b decision-gating, and CDR-SB as sole primary endpoint for Phase 3.
  • · Chi-separation MRI is a recently validated technique deployable across standard multi-site infrastructure.
  • · Preclinical models consistently showed XPro's effect on myelin biology, aligning with these clinical results.
Evommune, Inc. 8-K neutral materiality 3/10

02-06-2026

Evommune, Inc. held its 2026 Annual Meeting on June 2, 2026, where stockholders elected two directors and ratified BDO USA, P.C. as independent auditor for fiscal year 2026. Luis Peña received 21,859,596 votes for and 1,949,148 withheld, while Eugene Bauer received 23,637,920 for and 170,824 withheld. The auditor ratification passed overwhelmingly with 24,664,299 votes for, 430 against, and 29,765 abstentions.

  • · The annual meeting was held on June 2, 2026, with a quorum present.
  • · Both director nominees were elected to serve until the 2029 Annual Meeting.
  • · Broker non-votes for director election totaled 885,750 shares.
  • · Auditor ratification had minimal opposition: only 430 votes against and 29,765 abstentions.
KENNAMETAL INC 8-K mixed materiality 8/10

02-06-2026

Kennametal Inc. entered into a First Amendment to its Seventh Amended and Restated Credit Agreement, increasing total commitments by $200 million to $850 million and adding a new $600 million Term Loan Credit Agreement. The company also added incremental debt capacity under a new basket of up to $350 million. Simultaneously, the total multicurrency subcommitment was set at $300 million.

  • · The existing credit facility total commitments increased from $650 million to $850 million.
  • · A new Term Loan Credit Agreement was entered into on the same date, permitting up to $600 million in unsecured indebtedness for the Company.
  • · An additional debt basket of $350 million (plus Attributable Debt from Qualified Receivables Transactions) was added for future borrowings and subsidiaries.
  • · The amendment also increased the multicurrency subcommitment to $300 million.
  • · The First Amendment Effective Date is May 28, 2026.
SAGA COMMUNICATIONS INC 8-K mixed materiality 5/10

02-06-2026

Saga Communications held its Annual Meeting on June 1, 2026, where all seven director nominees were elected and shareholders approved the ratification of Crowe LLP as independent auditor and the non-binding advisory vote on executive compensation. The results reflect strong shareholder support for the auditor (5,571,362 votes for vs. 24,494 against) but revealed significant dissent on say-on-pay, with 1,760,704 votes against and 863,982 broker non-votes, totaling substantial opposition.

  • · All seven director nominees were elected with votes ranging from 2,871,665 (Clarke R. Brown, Jr.) to 3,696,203 (Christopher S. Forgy) in favor.
  • · The auditor ratification passed with 99.6% approval; only 24,494 shares voted against.
  • · Say-on-pay received 63.2% approval (3,020,736 for vs. 1,760,704 against), indicating notable shareholder pushback on executive compensation.
  • · Broker non-votes totaled 863,982 shares across all director elections and the say-on-pay proposal.

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 28 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Nasdaq 100 Stocks SEC Filings

🇺🇸 More from United States

View all →